Donald Foster
Overview
Explore the profile of Donald Foster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bates E, Kipp Z, Martinez G, Badmus O, Soundarapandian M, Foster D, et al.
Biomolecules
. 2023 Feb;
13(2).
PMID: 36830621
Several population studies have observed lower serum bilirubin levels in patients with non-alcoholic fatty liver disease (NAFLD). Yet, treatments to target this metabolic phenotype have not been explored. Therefore, we...
2.
Lambroussis C, Foster D, Sharma A
Cureus
. 2022 Sep;
14(8):e27702.
PMID: 36081977
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by venous or arterial thrombosis and/or pregnancy morbidity in the presence of persistent laboratory evidence of antiphospholipid antibodies (APL). APS can...
3.
Brown K, Nair J, Janas M, Anglero-Rodriguez Y, Dang L, Peng H, et al.
Nat Biotechnol
. 2022 Jun;
40(10):1500-1508.
PMID: 35654979
Therapeutics based on short interfering RNAs (siRNAs) delivered to hepatocytes have been approved, but new delivery solutions are needed to target additional organs. Here we show that conjugation of 2'-O-hexadecyl...
4.
Chang T, Foster D, Kahn A
J Res Natl Bur Stand (1977)
. 2021 Sep;
83(2):133-164.
PMID: 34565976
We report on the preparation of a standard reference material (SRM), made of single-crystal chromium-doped corundum (synthetic ruby), for use as an intensity standard in electron paramagnetic resonance (EPR) experiments....
5.
Zeevi A, Marrari M, Lunz J, Lomago J, Johnson K, Jelinek L, et al.
Clin Transpl
. 2014 Aug;
:399-405.
PMID: 25095535
We report the case of a patient who developed respiratory failure in the presence of de novo donor-specific antibody (DSA) two years after lung transplantation, following recurrent acute cellular rejection....
6.
Tummala S, Titus M, Wilson L, Wang C, Ciatto C, Thill G, et al.
Biotechnol Prog
. 2012 Nov;
29(2):415-24.
PMID: 23172735
Traditional metabolic engineering approaches, including homologous recombination, zinc-finger nucleases, and short hairpin RNA, have previously been used to generate biologics with specific characteristics that improve efficacy, potency, and safety. An...
7.
Ward C, Artz L, Berg J, Boonzaier F, Crawford-Browne S, Dawes A, et al.
S Afr Med J
. 2012 Apr;
102(4):215-8.
PMID: 22464496
Violence is a serious problem in South Africa with many effects on health services; it presents complex research problems and requires interdisciplinary collaboration. Two key meta-questions emerge: (i) violence must...
8.
Lewis T, Abanobi B, Alleman P, Ballinas E, Botbyl B, Bries G, et al.
Crit Care Nurs Clin North Am
. 2005 May;
17(2):149-54, x.
PMID: 15862737
This article features the Coronary Care Unit of The Methodist Hospital of Houston, Texas. This unit was one of the first Beacon Critical Care Units recognized by the American Association...
9.
Chand H, Du X, Ma D, Inzunza H, Kamei S, Foster D, et al.
Blood
. 2003 Oct;
103(3):1069-77.
PMID: 14525759
Human tissue factor pathway inhibitor-2 (TFPI-2) is a matrix-associated Kunitz inhibitor that inhibits the plasmin- and trypsin-mediated activation of zymogen matrix metalloproteinases involved in tumor progression, invasion, and metastasis. To...
10.
Stone M, Harvey S, Kisiel W, Foster D, Nelsestuen G
Biochemistry
. 2002 Dec;
41(52):15820-5.
PMID: 12501211
Protein modification with poly(ethylene glycol) (PEG) can prolong circulatory lifetime and lower protein antigenicity in an animal. These benefits may arise from the proposed mechanism of PEG action, molecular shielding...